What MoCRA actually requires, who's exempt, what a cosmetics registrar handles, and how to choose one — without the marketing superlatives.
| Requirement | What it means | Cadence |
|---|---|---|
| Facility registration | Register the facility via Cosmetics Direct (Form FDA 5066); foreign facilities add a U.S. Agent | Biennial renewal; update within 60 days |
| Cosmetic product listing | List each product (ingredients, category, facility) in SPL — Form FDA 5067 | Update at least annually |
| Responsible Person | The manufacturer/packer/distributor on the label; accountable party | Ongoing |
| Safety substantiation | Maintain records of adequate safety substantiation for every product | Ongoing |
| Adverse-event reporting | Report serious adverse events; keep records 6 yrs (3 for small business) | Within 15 business days |
| GMP | Cosmetic Good Manufacturing Practice | Via forthcoming FDA rulemaking |
| Labeling | Domestic contact for adverse-event reports; professional-use labeling (21 CFR 701) | Ongoing |
Generally must register & list:
The small-business exemption — average annual U.S. cosmetic sales under $1M over the prior 3 years — exempts you from registration, listing, and GMP, but not if your product:
MoCRA applies to cosmetics — products intended to cleanse or beautify. If your product makes a drug claim (treats a condition, or affects the body's structure/function), it's an OTC drug, or a drug/cosmetic combination, with a different and heavier set of rules. This matters before you register: getting the classification wrong means building compliance on the wrong pathway.
A registrar manages the MoCRA lifecycle end to end:
Cosmetics don't need FDA pre-market approval (color additives are the exception). MoCRA registration and product listing put your facility and products in FDA's database — they are not an approval or endorsement of safety. The Responsible Person is responsible for ensuring the product is safe before it's marketed.
FDA Registration Assistance manages the MoCRA lifecycle: facility registration through Cosmetics Direct, cosmetic product listing for each SKU, Responsible Person and safety-substantiation guidance, adverse-event reporting processes, a U.S. Agent for foreign facilities, label review, and ongoing biennial renewals and annual updates.
We're an independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience and BBB accreditation — and we describe our role plainly. Contact info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote.
A cosmetics registrar handles your MoCRA compliance lifecycle: facility registration with FDA (via Cosmetics Direct), cosmetic product listing for each marketed product, Responsible Person and safety-substantiation support, adverse-event reporting processes, a U.S. Agent for foreign facilities, and ongoing biennial renewals and annual listing updates. The value isn't a one-time submission — it's keeping the registration, listings, and records accurate and current as your product line changes.
MoCRA — the Modernization of Cosmetics Regulation Act of 2022 — is the most significant update to U.S. cosmetic regulation in decades. It made facility registration and product listing mandatory (they used to be voluntary), and it added requirements for a Responsible Person, safety substantiation, serious adverse-event reporting, cosmetic GMP (via forthcoming rulemaking), and specific labeling. It also gave FDA new authorities, including mandatory recall and records access.
Facilities — domestic or foreign — that manufacture or process cosmetic products for U.S. distribution generally must register with FDA. That includes contract manufacturers and private-label makers. Retailers, distributors that don't manufacture, and beauty salons that don't make product are generally not "facilities" for registration, though the Responsible Person still has product-listing and safety obligations. Correctly identifying your role (facility vs Responsible Person) is the first step.
The Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label. Under MoCRA, the Responsible Person is accountable for listing each product, maintaining adequate safety substantiation, reporting serious adverse events, and meeting labeling requirements. Every marketed cosmetic needs a Responsible Person — it's the accountable party, roughly the cosmetic counterpart to the importer's role under food's FSVP (though the rules differ).
Facility registration renews every two years (biennially), on the anniversary of your initial registration — not on the food industry's October–December calendar window. Product listings must be reviewed and updated at least annually. And any change to registration information must be reported within 60 days. Keeping these cycles is part of staying compliant; a lapse can put your products at risk of being treated as adulterated or misbranded.
The Responsible Person must list each marketed cosmetic product with FDA — including the ingredient list, product category, and the linked facility — submitted in Structured Product Labeling (SPL) format through Cosmetics Direct (Form FDA 5067). Listings must be updated at least annually and when the product changes (for example, a reformulation). Registration covers the facility; listing covers each product.
Yes. Under MoCRA, a foreign facility that manufactures or processes cosmetics for the U.S. must designate a U.S. Agent as part of its FDA facility registration — the U.S.-based point of contact for FDA. This is a genuine MoCRA requirement for cosmetics (unlike some cross-category confusion, it does apply here). A responsive U.S. Agent matters because FDA can suspend a facility's registration in serious situations, and communications need to be handled promptly.
MoCRA requires the Responsible Person to ensure — and keep records supporting — adequate safety substantiation for every cosmetic product. FDA doesn't mandate a specific test package, but the data must come from scientifically robust methods, and the old "safety not determined" warning statement is no longer a valid substitute. In practice this means stability, compatibility, microbial, and toxicological data as appropriate to the product, organized and ready for FDA.
The Responsible Person must report serious adverse events to FDA within 15 business days, and keep adverse-event records for six years (three years for small businesses). "Serious" includes outcomes like death, hospitalization, disfigurement, or significant events — and MoCRA expressly treats significant hair loss as a serious adverse event. Even small businesses that are exempt from registration/listing are not exempt from adverse-event reporting.
Yes, a limited one. Businesses whose average annual U.S. cosmetic sales are under $1 million over the prior three years are exempt from facility registration, product listing, and GMP. But the exemption does not apply to products that contact the eye's mucous membrane, are injected, are intended for internal use, or alter appearance for more than 24 hours without consumer removal. And no small business is ever exempt from safety substantiation, adverse-event reporting, or labeling requirements.
No. Cosmetics don't require FDA pre-market approval (color additives are the exception). MoCRA registration and product listing put your facility and products in FDA's database — they are not an approval or endorsement of safety. The Responsible Person is responsible for ensuring the product is safe before marketing. Claiming your cosmetic is "FDA-approved" or "FDA-registered and approved" is misleading and can itself be a labeling violation.
Beyond standard cosmetic labeling (21 CFR Part 701), MoCRA requires the label to include a domestic address, phone number, or electronic contact through which the Responsible Person can receive adverse-event reports, and products intended for professional use must be labeled accordingly. A fragrance-allergen disclosure requirement is coming through FDA rulemaking but isn't final yet. Labeling is part of the compliance picture, not separate from it.
You should come into compliance promptly. The statutory deadline for registration and listing has passed (FDA began enforcement on July 1, 2024), so unregistered facilities and unlisted products are exposed to enforcement, import issues, and marketplace removal. We can audit your current status, complete the facility registration and product listings, set up the Responsible Person and records, and get you current.
Look for full-lifecycle capability (registration, listing, Responsible Person support, U.S. Agent, renewals, and adverse-event processes — not just a one-time filing), responsiveness (FDA and marketplace issues move quickly), independence (a partner focused on your compliance), and a verifiable track record. Be skeptical of superlative claims like "the #1 rated" or "the only complete solution" — weigh demonstrable experience and the actual scope of service instead.
Yes. We can audit an existing MoCRA registration and product listings, correct errors, complete missing listings, designate or replace a U.S. Agent, set up the Responsible Person and safety/adverse-event records, and maintain the biennial renewal and annual updates going forward — whether you registered yourself or through another provider.
We manage the MoCRA lifecycle: facility registration through Cosmetics Direct, cosmetic product listing for each SKU, Responsible Person and safety-substantiation guidance, adverse-event reporting processes, a U.S. Agent for foreign facilities, label review, and ongoing biennial renewals and annual updates. We're an independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience and BBB accreditation — and we describe our role plainly rather than with superlatives. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.